Unlike most fad diets, this approach works by supporting your bodys natural appetite and weight-regulation systems
Prz Gastroenterol
Compounded drugs are not FDA approved, and the semaglutide shortage-related enforcement-discretion periods ended in 2025
The recurring themes are bundle pricing confusion (people charged $3,000+ thinking they were signing up monthly), a no-refund-once-shipped policy, and a cancellation process that requires a phone call with retention pressure
doi: 10.1038/nrendo.2012.140 [DOI] [PubMed] [Google Scholar] 55.Nauck MA, Quast DR, Wefers J, et al
FDA approves first generic GLP-1 for weight loss Teva has received US Food and Drug Administration (FDA) approval and launched the first generic GLP-1 drug for weight loss, a copy of Saxenda